{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:39:34Z","timestamp":1773941974406,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.mehy.2019.109436","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T11:56:39Z","timestamp":1571140599000},"page":"109436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"134","author":[{"given":"Yuhei","family":"Hasuike","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuyuki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiyo","family":"Koroyasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misa","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misaki","family":"Yamadera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harutoshi","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saburo","family":"Sakoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mehy.2019.109436_b0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.1016\/j.mehy.2019.109436_b0010","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u2019s disease:dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mehy.2019.109436_b0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/bs.irn.2017.05.034","article-title":"Osteoporosis: a hidden nonmotor face of Parkinson's disease","volume":"134","author":"Metta","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"2","key":"10.1016\/j.mehy.2019.109436_b0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afs161","article-title":"Parkinson's disease and osteoporosis","volume":"42","author":"van den Bos","year":"2013","journal-title":"Age Ageing"},{"issue":"8","key":"10.1016\/j.mehy.2019.109436_b0025","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00198-013-2300-2","article-title":"Risk of fracture in patients with Parkinson\u2019s disease","volume":"24","author":"Pouwels","year":"2013","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.mehy.2019.109436_b0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.parkreldis.2011.10.016","article-title":"Body mass index in Parkinson\u2019s disease:meta-analysis","volume":"18","author":"van der Marck","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1016\/j.mehy.2019.109436_b0035","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.10577","article-title":"Weight loss in Parkinson's disease","volume":"53","author":"Chen","year":"2003","journal-title":"Ann Neurol."},{"issue":"5","key":"10.1016\/j.mehy.2019.109436_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124541","article-title":"McFarland NR weight loss and impact on quality of life in Parkinson's disease","volume":"10","author":"Akbar","year":"2015","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.mehy.2019.109436_b0045","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1212\/WNL.0000000000004691","article-title":"Early weight loss in parkinsonism predicts poor outcomes: evidence from an incident cohort study","volume":"89","author":"Cumming","year":"2017","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.mehy.2019.109436_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075743","article-title":"Reduced serum levels of triglyceride, very low density lipoprotein cholesterol and apolipoprotein B in Parkinson's disease patients","volume":"8","author":"Wei","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mehy.2019.109436_b0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JPD-150615","article-title":"Systematic review of the relationship between VitaminD and Parkinson\u2019s disease","volume":"6","author":"Rimmelzwaan","year":"2016","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"10.1016\/j.mehy.2019.109436_b0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01999565","article-title":"Increased plasma bilirubin in Parkinson patients on L-dopa: evidence against the free radical hypothesis?","volume":"18","author":"Scigliano","year":"1997","journal-title":"Ital J Neurol Sci"},{"issue":"6","key":"10.1016\/j.mehy.2019.109436_b0065","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/ene.12688","article-title":"Increased bilirubin levels in de novo Parkinson\u2019s disease","volume":"22","author":"Moccia","year":"2015","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.mehy.2019.109436_b0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","article-title":"A timeline for Parkinson's disease","volume":"16","author":"Hawkes","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1016\/j.mehy.2019.109436_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2019.109436_b0080","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1146\/annurev-immunol-020711-074937","article-title":"The microbiome in infectious disease and inflammation","volume":"30","author":"Honda","year":"2012","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"10.1016\/j.mehy.2019.109436_b0085","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MOP.0000000000000234","article-title":"Influence of the human intestinal microbiome on obesity and metabolic dysfunction","volume":"27","author":"Tilg","year":"2015","journal-title":"Curr Opin Pediatr"},{"issue":"10","key":"10.1016\/j.mehy.2019.109436_b0090","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1124\/dmd.115.063826","article-title":"Microbiome disturbances and autism spectrum disorders","volume":"43","author":"Rosenfeld","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.mehy.2019.109436_b0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000103892","article-title":"Small intestinal bacterial overgrowth: diagnosis and treatment","volume":"25","author":"Gasbarrini","year":"2007","journal-title":"Dig Dis"},{"issue":"12","key":"10.1016\/j.mehy.2019.109436_b0100","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/MEG.0000000000000214","article-title":"Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease","volume":"26","author":"Kwak","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"24","key":"10.1016\/j.mehy.2019.109436_b0105","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","article-title":"Small intestinal bacterial overgrowth syndrome","volume":"16","author":"Bures","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.mehy.2019.109436_b0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00787-017-1039-2","article-title":"Hydrogen breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in autism","volume":"27","author":"Wang","year":"2018","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.mehy.2019.109436_b0115","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.mehy.2019.109436_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142164","article-title":"Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson\u2019s disease","volume":"10","author":"Hasegawa","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.mehy.2019.109436_b0125","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.mehy.2019.109436_b0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.parkreldis.2014.12.009","article-title":"Helicobacter pylori infection is associated with worse severity of Parkinson\u2019s disease","volume":"21","author":"Tan","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1016\/j.mehy.2019.109436_b0135","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.23566","article-title":"Prevalence of small intestinal bacterial overgrowth in Parkinson's disease","volume":"26","author":"Gabrielli","year":"2011","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.mehy.2019.109436_b0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.parkreldis.2014.02.019","article-title":"Small intestinal bacterial overgrowth in Parkinson\u2019s disease","volume":"20","author":"Tan","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"10.1016\/j.mehy.2019.109436_b0145","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/mds.25522","article-title":"The role of small intestinal bacterial overgrowth in Parkinson's disease","volume":"28","author":"Fasano","year":"2013","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.mehy.2019.109436_b0150","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00702-016-1612-8","article-title":"Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease","volume":"123","author":"Niu","year":"2016","journal-title":"J Neural Transm"},{"issue":"2","key":"10.1016\/j.mehy.2019.109436_b0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1515\/revneuro-2011-0072","article-title":"A historical justifi cation for and retrospective analysis of the systematic application of light therapy in Parkinson\u2019s disease","volume":"23","author":"Willis","year":"2012","journal-title":"Rev Neurosci"},{"issue":"5","key":"10.1016\/j.mehy.2019.109436_b0160","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbagen.2011.05.006","article-title":"Molecular hydrogen is a novel antioxidant to efficiently reduce oxidative stress with potential for the improvement of mitochondrial diseases","volume":"1820","author":"Ohta","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2019.109436_b0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","article-title":"Induction of colonic regulatory T cells by indigenous Clostridium species","volume":"331","author":"Atarashi","year":"2011","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.mehy.2019.109436_b0170","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1021\/cr050196r","article-title":"Occurrence, classification, and biological function of hydrogenases:an overview","volume":"107","author":"Vignais","year":"2007","journal-title":"Chem Rev"},{"issue":"2","key":"10.1016\/j.mehy.2019.109436_b0175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2004.10.012","article-title":"The impact of intestinal microflora on serum bilirubin levels","volume":"42","author":"Vitek","year":"2005","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.mehy.2019.109436_b0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0095-5108(05)70012-9","article-title":"Bilirubin and jaundice in the micropremie","volume":"27","author":"Cashore","year":"2000","journal-title":"Clin Perinatol"},{"issue":"3","key":"10.1016\/j.mehy.2019.109436_b0185","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/QCO.0000000000000061","article-title":"The neonatal bowel microbiome in health and infection","volume":"27","author":"Berrington","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.mehy.2019.109436_b0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.anaerobe.2012.11.001","article-title":"Assessment of intestinal microbiota modulation ability of Bifidobacterium strains in in vitro fecal batch cultures from preterm neonates","volume":"19","author":"Arbolena","year":"2013","journal-title":"Anaerobe"},{"issue":"1","key":"10.1016\/j.mehy.2019.109436_b0195","first-page":"61","article-title":"Analysis of instestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods","volume":"30","author":"Harmsen","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4899","key":"10.1016\/j.mehy.2019.109436_b0200","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1136\/bmj.2.4899.1263","article-title":"Increased plasma bilirubin in newborn infants in relation to birth weight","volume":"2","author":"Billing","year":"1954","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.mehy.2019.109436_b0205","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MPG.0b013e31827a964b","article-title":"Breast milk jaundice:effect of bacteria present in breast milk and infant feces","volume":"56","author":"Tuzun","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"10.1016\/j.mehy.2019.109436_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187307","article-title":"Progression of Parkinson's disease is associated with gut dysbiosis: two-year follow-up study","volume":"12","author":"Minato","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mehy.2019.109436_b0215","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1517\/14712598.2014.880420","article-title":"The human microbiome and bile acid metabolism:dysbiosis, dysmetabolism, disease and intervention","volume":"14","author":"Johns","year":"2014","journal-title":"Expert Opin, Biol Ther"},{"issue":"3","key":"10.1016\/j.mehy.2019.109436_b0220","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1124\/jpet.109.160093","article-title":"Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression","volume":"331","author":"Miyata","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.mehy.2019.109436_b0225","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.femsre.2004.09.003","article-title":"The interaction between bacteria and bile","volume":"29","author":"Gahan","year":"2005","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.mehy.2019.109436_b0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.parkreldis.2018.06.020","article-title":"Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease","volume":"56","author":"Tan","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.mehy.2019.109436_b0235","article-title":"Parkinson's disease and the gastrointestinal microbiome","author":"Lubomski","year":"2019","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.mehy.2019.109436_b0240","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bone.2012.09.013","article-title":"Osteoporosis risk and bone mineral density levels in patients with Parkinson's disease: a meta-analysis","volume":"52","author":"Zhao","year":"2013","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.mehy.2019.109436_b0245","first-page":"728","article-title":"Gallstone and Parkinson\u2019s disease \u2013Ultrasound echography study","volume":"30","author":"Maki","year":"1990","journal-title":"Rinsho Shinkeigaku"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719307418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719307418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:19:54Z","timestamp":1759691994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719307418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":49,"alternative-id":["S0306987719307418"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109436","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109436"}}